APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Parvovirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Animal Parvovirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025196 pages

Choose your research edition.

Industry ResearchAnimal Parvovirus Vaccine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Parvovirus Vaccine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Animal Parvovirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Parvovirus Vaccine Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Parvovirus Vaccine Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Animal Parvovirus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Animal Parvovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Animal Parvovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Parvovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Animal Parvovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Animal Parvovirus Vaccine include China Animal Husbandy Industry, Ringpu Bio-technology, Qilu Animal Health Products, Pulike Biological, Keqian Biology, Hile Biological, Harbin Pharmaceutical Group, DHN and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Animal Parvovirus Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal Parvovirus Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal Parvovirus Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Animal Parvovirus Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Animal Parvovirus Vaccine Segment by Company

China Animal Husbandy Industry

Ringpu Bio-technology

Qilu Animal Health Products

Pulike Biological

Keqian Biology

Hile Biological

Harbin Pharmaceutical Group

DHN

Zoetis

Virbac

Merck Animal Health

HIPRA

Elanco

Ceva Animal Health

Boehringer Ingelheim

Bioveta

Animal Parvovirus Vaccine Segment by Type

Individual Vaccine

Combination Vaccine

Animal Parvovirus Vaccine Segment by Application

Porcine

Canine

Feline

Others

Animal Parvovirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Parvovirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Parvovirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Parvovirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Animal Parvovirus Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Animal Parvovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Animal Parvovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Animal Parvovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Animal Parvovirus Vaccine Industry Trends Table 2. Animal Parvovirus Vaccine Industry Drivers Table 3. Animal Parvovirus Vaccine Industry Opportunities and Challenges Table 4. Animal Parvovirus Vaccine Industry Restraints Table 5. Global Animal Parvovirus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Animal Parvovirus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Animal Parvovirus Vaccine Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Animal Parvovirus Vaccine Sales Market Share by Manufacturers Table 9. Global Animal Parvovirus Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Animal Parvovirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Animal Parvovirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Animal Parvovirus Vaccine Manufacturers, Product Type & Application Table 13. Global Animal Parvovirus Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Animal Parvovirus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Individual Vaccine Table 17. Major Manufacturers of Combination Vaccine Table 18. Global Animal Parvovirus Vaccine Sales by Type 2021 VS 2025 VS 2032 (Units) Table 19. Global Animal Parvovirus Vaccine Sales by Type (2021-2026) & (Units) Table 20. Global Animal Parvovirus Vaccine Sales by Type (2027-2032) & (Units) Table 21. Global Animal Parvovirus Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Animal Parvovirus Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Animal Parvovirus Vaccine Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 24. Global Animal Parvovirus Vaccine Revenue by Type (2021-2026) & (Units) Table 25. Global Animal Parvovirus Vaccine Revenue by Type (2027-2032) & (Units) Table 26. Global Animal Parvovirus Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Animal Parvovirus Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Porcine Table 29. Major Manufacturers of Canine Table 30. Major Manufacturers of Feline Table 31. Major Manufacturers of Others Table 32. Global Animal Parvovirus Vaccine Sales by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Animal Parvovirus Vaccine Sales by Application (2021-2026) & (Units) Table 34. Global Animal Parvovirus Vaccine Sales by Application (2027-2032) & (Units) Table 35. Global Animal Parvovirus Vaccine Sales Market Share by Application (2021-2026) Table 36. Global Animal Parvovirus Vaccine Sales Market Share by Application (2027-2032) Table 37. Global Animal Parvovirus Vaccine Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 38. Global Animal Parvovirus Vaccine Revenue by Application (2021-2026) & (Units) Table 39. Global Animal Parvovirus Vaccine Revenue by Application (2027-2032) & (Units) Table 40. Global Animal Parvovirus Vaccine Revenue Market Share by Application (2021-2026) Table 41. Global Animal Parvovirus Vaccine Revenue Market Share by Application (2027-2032) Table 42. Global Animal Parvovirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Animal Parvovirus Vaccine Sales by Region (2021-2026) & (Units) Table 44. Global Animal Parvovirus Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Animal Parvovirus Vaccine Sales Forecasted by Region (2027-2032) & (Units) Table 46. Global Animal Parvovirus Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Animal Parvovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 48. North America Animal Parvovirus Vaccine Sales by Country (2021-2026) & (Units) Table 49. North America Animal Parvovirus Vaccine Sales by Country (2027-2032) & (Units) Table 50. Europe Animal Parvovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 51. Europe Animal Parvovirus Vaccine Sales by Country (2021-2026) & (Units) Table 52. Europe Animal Parvovirus Vaccine Sales by Country (2027-2032) & (Units) Table 53. Asia Pacific Animal Parvovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Asia Pacific Animal Parvovirus Vaccine Sales by Country (2021-2026) & (Units) Table 55. Asia Pacific Animal Parvovirus Vaccine Sales by Country (2027-2032) & (Units) Table 56. South America, Middle East and Africa Animal Parvovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 57. South America, Middle East and Africa Animal Parvovirus Vaccine Sales by Country (2021-2026) & (Units) Table 58. South America, Middle East and Africa Animal Parvovirus Vaccine Sales by Country (2027-2032) & (Units) Table 59. Global Animal Parvovirus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Animal Parvovirus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Animal Parvovirus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Animal Parvovirus Vaccine Revenue Market Share by Region (2021-2026) Table 63. Global Animal Parvovirus Vaccine Revenue Market Share by Region (2027-2032) Table 64. China Animal Husbandy Industry Company Information Table 65. China Animal Husbandy Industry Business Overview Table 66. China Animal Husbandy Industry Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. China Animal Husbandy Industry Animal Parvovirus Vaccine Product Portfolio Table 68. China Animal Husbandy Industry Recent Development Table 69. Ringpu Bio-technology Company Information Table 70. Ringpu Bio-technology Business Overview Table 71. Ringpu Bio-technology Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Ringpu Bio-technology Animal Parvovirus Vaccine Product Portfolio Table 73. Ringpu Bio-technology Recent Development Table 74. Qilu Animal Health Products Company Information Table 75. Qilu Animal Health Products Business Overview Table 76. Qilu Animal Health Products Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Qilu Animal Health Products Animal Parvovirus Vaccine Product Portfolio Table 78. Qilu Animal Health Products Recent Development Table 79. Pulike Biological Company Information Table 80. Pulike Biological Business Overview Table 81. Pulike Biological Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Pulike Biological Animal Parvovirus Vaccine Product Portfolio Table 83. Pulike Biological Recent Development Table 84. Keqian Biology Company Information Table 85. Keqian Biology Business Overview Table 86. Keqian Biology Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Keqian Biology Animal Parvovirus Vaccine Product Portfolio Table 88. Keqian Biology Recent Development Table 89. Hile Biological Company Information Table 90. Hile Biological Business Overview Table 91. Hile Biological Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Hile Biological Animal Parvovirus Vaccine Product Portfolio Table 93. Hile Biological Recent Development Table 94. Harbin Pharmaceutical Group Company Information Table 95. Harbin Pharmaceutical Group Business Overview Table 96. Harbin Pharmaceutical Group Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Harbin Pharmaceutical Group Animal Parvovirus Vaccine Product Portfolio Table 98. Harbin Pharmaceutical Group Recent Development Table 99. DHN Company Information Table 100. DHN Business Overview Table 101. DHN Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. DHN Animal Parvovirus Vaccine Product Portfolio Table 103. DHN Recent Development Table 104. Zoetis Company Information Table 105. Zoetis Business Overview Table 106. Zoetis Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Zoetis Animal Parvovirus Vaccine Product Portfolio Table 108. Zoetis Recent Development Table 109. Virbac Company Information Table 110. Virbac Business Overview Table 111. Virbac Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Virbac Animal Parvovirus Vaccine Product Portfolio Table 113. Virbac Recent Development Table 114. Merck Animal Health Company Information Table 115. Merck Animal Health Business Overview Table 116. Merck Animal Health Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Merck Animal Health Animal Parvovirus Vaccine Product Portfolio Table 118. Merck Animal Health Recent Development Table 119. HIPRA Company Information Table 120. HIPRA Business Overview Table 121. HIPRA Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. HIPRA Animal Parvovirus Vaccine Product Portfolio Table 123. HIPRA Recent Development Table 124. Elanco Company Information Table 125. Elanco Business Overview Table 126. Elanco Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Elanco Animal Parvovirus Vaccine Product Portfolio Table 128. Elanco Recent Development Table 129. Ceva Animal Health Company Information Table 130. Ceva Animal Health Business Overview Table 131. Ceva Animal Health Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Ceva Animal Health Animal Parvovirus Vaccine Product Portfolio Table 133. Ceva Animal Health Recent Development Table 134. Boehringer Ingelheim Company Information Table 135. Boehringer Ingelheim Business Overview Table 136. Boehringer Ingelheim Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Boehringer Ingelheim Animal Parvovirus Vaccine Product Portfolio Table 138. Boehringer Ingelheim Recent Development Table 139. Bioveta Company Information Table 140. Bioveta Business Overview Table 141. Bioveta Animal Parvovirus Vaccine Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Bioveta Animal Parvovirus Vaccine Product Portfolio Table 143. Bioveta Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Animal Parvovirus Vaccine Distributors List Table 147. Animal Parvovirus Vaccine Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Animal Parvovirus Vaccine Product Image Figure 2. Global Animal Parvovirus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Parvovirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Animal Parvovirus Vaccine Sales (2021-2032) & (Units) Figure 5. Global Animal Parvovirus Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Animal Parvovirus Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Individual Vaccine Image Figure 9. Combination Vaccine Image Figure 10. Global Animal Parvovirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 11. Global Animal Parvovirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Animal Parvovirus Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Animal Parvovirus Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Animal Parvovirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Animal Parvovirus Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Porcine Image Figure 17. Canine Image Figure 18. Feline Image Figure 19. Others Image Figure 20. Global Animal Parvovirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Animal Parvovirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Animal Parvovirus Vaccine Sales Market Share by Application (2021-2032) Figure 23. Global Animal Parvovirus Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global Animal Parvovirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Animal Parvovirus Vaccine Revenue Market Share by Application (2021-2032) Figure 26. North America Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 27. North America Animal Parvovirus Vaccine Sales Market Share by Country (2021-2032) Figure 28. U.S. Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 29. Canada Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 30. Mexico Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 32. Europe Animal Parvovirus Vaccine Sales Market Share by Country (2021-2032) Figure 33. Germany Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 34. France Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 35. U.K. Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 36. Italy Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 37. Netherlands Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 39. Asia Pacific Animal Parvovirus Vaccine Sales Market Share by Country (2021-2032) Figure 40. China Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 41. Japan Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 42. South Korea Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 43. Southeast Asia Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 44. India Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 45. Australia Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 47. South America, Middle East and Africa Animal Parvovirus Vaccine Sales Market Share by Country (2021-2032) Figure 48. Brazil Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 49. South Africa Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 50. Saudi Arabia Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 51. Turkey Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 52. Argentina Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 53. UAE Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 54. Egypt Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 55. Chile Animal Parvovirus Vaccine Sales and Growth Rate (2021-2032) & (Units) Figure 56. Global Animal Parvovirus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Animal Parvovirus Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Animal Parvovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. North America Animal Parvovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Animal Parvovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Animal Parvovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Animal Parvovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Animal Parvovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Animal Parvovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Animal Parvovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Animal Parvovirus Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Animal Parvovirus Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Individual Vaccine
  • Combination Vaccine
Applications
  • Porcine
  • Canine
  • Feline
  • Others
Companies covered
  • China Animal Husbandy Industry
  • Ringpu Bio-technology
  • Qilu Animal Health Products
  • Pulike Biological
  • Keqian Biology
  • Hile Biological
  • Harbin Pharmaceutical Group
  • DHN
  • Zoetis
  • Virbac
  • Merck Animal Health
  • HIPRA
  • Elanco
  • Ceva Animal Health
  • Boehringer Ingelheim
  • Bioveta

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Animal Parvovirus Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Animal Parvovirus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Animal Parvovirus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Animal Parvovirus Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Animal Parvovirus Vaccine Market Dynamics
  1. 2.1 Animal Parvovirus Vaccine Industry Trends
  2. 2.2 Animal Parvovirus Vaccine Industry Drivers
  3. 2.3 Animal Parvovirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Animal Parvovirus Vaccine Industry Restraints
3 Animal Parvovirus Vaccine Market by Manufacturers
  1. 3.1 Global Animal Parvovirus Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Animal Parvovirus Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Animal Parvovirus Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Animal Parvovirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Animal Parvovirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Animal Parvovirus Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Animal Parvovirus Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Animal Parvovirus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Animal Parvovirus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Animal Parvovirus Vaccine Tier 1, Tier 2, and Tier 3
4 Animal Parvovirus Vaccine Market by Type
  1. 4.1 Animal Parvovirus Vaccine Type Introduction
  2. 4.1.1 Individual Vaccine
  3. 4.1.2 Combination Vaccine
  4. 4.2 Global Animal Parvovirus Vaccine Sales by Type
  5. 4.2.1 Global Animal Parvovirus Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Animal Parvovirus Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Animal Parvovirus Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Animal Parvovirus Vaccine Revenue by Type
  9. 4.3.1 Global Animal Parvovirus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Animal Parvovirus Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Animal Parvovirus Vaccine Revenue Market Share by Type (2021-2032)
5 Animal Parvovirus Vaccine Market by Application
  1. 5.1 Animal Parvovirus Vaccine Application Introduction
  2. 5.1.1 Porcine
  3. 5.1.2 Canine
  4. 5.1.3 Feline
  5. 5.1.4 Others
  6. 5.2 Global Animal Parvovirus Vaccine Sales by Application
  7. 5.2.1 Global Animal Parvovirus Vaccine Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Animal Parvovirus Vaccine Sales by Application (2021-2032)
  9. 5.2.3 Global Animal Parvovirus Vaccine Sales Market Share by Application (2021-2032)
  10. 5.3 Global Animal Parvovirus Vaccine Revenue by Application
  11. 5.3.1 Global Animal Parvovirus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Animal Parvovirus Vaccine Revenue by Application (2021-2032)
  13. 5.3.3 Global Animal Parvovirus Vaccine Revenue Market Share by Application (2021-2032)
6 Global Animal Parvovirus Vaccine Sales by Region
  1. 6.1 Global Animal Parvovirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal Parvovirus Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Animal Parvovirus Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Animal Parvovirus Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Animal Parvovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Animal Parvovirus Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Animal Parvovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Animal Parvovirus Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Animal Parvovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Animal Parvovirus Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Animal Parvovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Animal Parvovirus Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Animal Parvovirus Vaccine Revenue by Region
  1. 7.1 Global Animal Parvovirus Vaccine Revenue by Region
  2. 7.1.1 Global Animal Parvovirus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Animal Parvovirus Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Animal Parvovirus Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Animal Parvovirus Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Animal Parvovirus Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Animal Parvovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Animal Parvovirus Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Animal Parvovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Animal Parvovirus Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Animal Parvovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Animal Parvovirus Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Animal Parvovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 China Animal Husbandy Industry
  2. 8.1.1 China Animal Husbandy Industry Company Information
  3. 8.1.2 China Animal Husbandy Industry Business Overview
  4. 8.1.3 China Animal Husbandy Industry Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 China Animal Husbandy Industry Animal Parvovirus Vaccine Product Portfolio
  6. 8.1.5 China Animal Husbandy Industry Recent Developments
  7. 8.2 Ringpu Bio-technology
  8. 8.2.1 Ringpu Bio-technology Company Information
  9. 8.2.2 Ringpu Bio-technology Business Overview
  10. 8.2.3 Ringpu Bio-technology Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ringpu Bio-technology Animal Parvovirus Vaccine Product Portfolio
  12. 8.2.5 Ringpu Bio-technology Recent Developments
  13. 8.3 Qilu Animal Health Products
  14. 8.3.1 Qilu Animal Health Products Company Information
  15. 8.3.2 Qilu Animal Health Products Business Overview
  16. 8.3.3 Qilu Animal Health Products Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Animal Health Products Animal Parvovirus Vaccine Product Portfolio
  18. 8.3.5 Qilu Animal Health Products Recent Developments
  19. 8.4 Pulike Biological
  20. 8.4.1 Pulike Biological Company Information
  21. 8.4.2 Pulike Biological Business Overview
  22. 8.4.3 Pulike Biological Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pulike Biological Animal Parvovirus Vaccine Product Portfolio
  24. 8.4.5 Pulike Biological Recent Developments
  25. 8.5 Keqian Biology
  26. 8.5.1 Keqian Biology Company Information
  27. 8.5.2 Keqian Biology Business Overview
  28. 8.5.3 Keqian Biology Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Keqian Biology Animal Parvovirus Vaccine Product Portfolio
  30. 8.5.5 Keqian Biology Recent Developments
  31. 8.6 Hile Biological
  32. 8.6.1 Hile Biological Company Information
  33. 8.6.2 Hile Biological Business Overview
  34. 8.6.3 Hile Biological Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hile Biological Animal Parvovirus Vaccine Product Portfolio
  36. 8.6.5 Hile Biological Recent Developments
  37. 8.7 Harbin Pharmaceutical Group
  38. 8.7.1 Harbin Pharmaceutical Group Company Information
  39. 8.7.2 Harbin Pharmaceutical Group Business Overview
  40. 8.7.3 Harbin Pharmaceutical Group Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Harbin Pharmaceutical Group Animal Parvovirus Vaccine Product Portfolio
  42. 8.7.5 Harbin Pharmaceutical Group Recent Developments
  43. 8.8 DHN
  44. 8.8.1 DHN Company Information
  45. 8.8.2 DHN Business Overview
  46. 8.8.3 DHN Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 DHN Animal Parvovirus Vaccine Product Portfolio
  48. 8.8.5 DHN Recent Developments
  49. 8.9 Zoetis
  50. 8.9.1 Zoetis Company Information
  51. 8.9.2 Zoetis Business Overview
  52. 8.9.3 Zoetis Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Animal Parvovirus Vaccine Product Portfolio
  54. 8.9.5 Zoetis Recent Developments
  55. 8.10 Virbac
  56. 8.10.1 Virbac Company Information
  57. 8.10.2 Virbac Business Overview
  58. 8.10.3 Virbac Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Virbac Animal Parvovirus Vaccine Product Portfolio
  60. 8.10.5 Virbac Recent Developments
  61. 8.11 Merck Animal Health
  62. 8.11.1 Merck Animal Health Company Information
  63. 8.11.2 Merck Animal Health Business Overview
  64. 8.11.3 Merck Animal Health Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Merck Animal Health Animal Parvovirus Vaccine Product Portfolio
  66. 8.11.5 Merck Animal Health Recent Developments
  67. 8.12 HIPRA
  68. 8.12.1 HIPRA Company Information
  69. 8.12.2 HIPRA Business Overview
  70. 8.12.3 HIPRA Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 HIPRA Animal Parvovirus Vaccine Product Portfolio
  72. 8.12.5 HIPRA Recent Developments
  73. 8.13 Elanco
  74. 8.13.1 Elanco Company Information
  75. 8.13.2 Elanco Business Overview
  76. 8.13.3 Elanco Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Elanco Animal Parvovirus Vaccine Product Portfolio
  78. 8.13.5 Elanco Recent Developments
  79. 8.14 Ceva Animal Health
  80. 8.14.1 Ceva Animal Health Company Information
  81. 8.14.2 Ceva Animal Health Business Overview
  82. 8.14.3 Ceva Animal Health Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ceva Animal Health Animal Parvovirus Vaccine Product Portfolio
  84. 8.14.5 Ceva Animal Health Recent Developments
  85. 8.15 Boehringer Ingelheim
  86. 8.15.1 Boehringer Ingelheim Company Information
  87. 8.15.2 Boehringer Ingelheim Business Overview
  88. 8.15.3 Boehringer Ingelheim Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Boehringer Ingelheim Animal Parvovirus Vaccine Product Portfolio
  90. 8.15.5 Boehringer Ingelheim Recent Developments
  91. 8.16 Bioveta
  92. 8.16.1 Bioveta Company Information
  93. 8.16.2 Bioveta Business Overview
  94. 8.16.3 Bioveta Animal Parvovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Bioveta Animal Parvovirus Vaccine Product Portfolio
  96. 8.16.5 Bioveta Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Animal Parvovirus Vaccine Value Chain Analysis
  2. 9.1.1 Animal Parvovirus Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Animal Parvovirus Vaccine Production Mode & Process
  6. 9.2 Animal Parvovirus Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Animal Parvovirus Vaccine Distributors
  9. 9.2.3 Animal Parvovirus Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst